Towa Of Japan To Build Plant Expanding Pill Capacity By 50 Percent
This article was originally published in PharmAsia News
Executive Summary
Japan's Towa Pharmaceutical plans to invest $208.4 million in a new plant to increase its capacity to produce generic drugs. The factory expects to open in March 2012, with an emphasis on producing drugs for treating diabetes and similar diseases. Although no specific drugs were identified, Towa also plans to include within the new plant a facility for producing cancer drugs. In all, Towa expects the plant to increase its total dose capacity by about 50 percent. (Click here for more - a subscription may be required